About Alzheimer's

The hypothesis comes from the University of Florida's McKnight Brain Institute Center for Smell and Taste, and seems to show already the first positive results in the research of one of the most important diseases of cognitive degenerative diseases.
Alzheimer's is a disease that shows up in the early stages symptoms similar to that of the normal senile dementia, making it difficult identifying her quickly. Thanks to a jar of peanut butter and a metre, the researchers provide to be able to develop an effective tool to detect the disease in an economical way and already during the first stages of progress, when the symptoms are still poor or almost absent.
The central node of the test, the olfactory system, where the nerve lies in the frontal region of the skull and that seems to be one of the first to be affected by the disease. Here comes the peanut butter, a small amount is placed in a jar and approached in a progressive manner to the subject, measuring with the meter the distance from the nose.
Eyes closed and one of the two nostrils plugged during the test. The procedure is repeated two times, once for each nostril, with an interval of 90 seconds. Most of the 90 subjects involved in the experiment, divided between subjects with forms of moderate degeneration, cognitive, Alzheimer, dementia, and healthy volunteers.

All the 18 patients with Alzheimer's disease have shown that there is an important disparity in the response and in the nose of the two nostrils, the left has shown the need for a greater closeness of the jar containing peanut butter for the detection of odor, an average of 10 centimeters.
The same data is not also been found in healthy subjects, who have not reported significant differences between the two nostrils, while subjects suffering from other forms of cognitive deficits have shown poor disparities even if in favour of the right nostril.
As stated in the Dr. ssa Jennifer Stamp, who conducted the research, it is a process that needs a tune-up before you can become a fully reliable and secure. An eventuality that, however, is not excluded, but rather will be in-depth with further evidence:
At the moment we can use this test only for the confirmation of the diagnosis, but we have as its objective the study of patients with moderate disparities in cognitive for vederificare if this test can be used to discover which patients will manifest Alzheimer's disease.